Cargando…
Acute Ischemic and Hemorrhagic Stroke in COVID-19: Mounting Evidence
The novel coronavirus disease of 2019 (COVID-19) is caused by the binding of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to angiotensin-converting enzyme 2 (ACE2) receptors present on various locations such as the pulmonary alveolar epithelium and vascular endothelium. In COVID-19 p...
Autores principales: | Rajdev, Kartikeya, Lahan, Shubham, Klein, Kate, Piquette, Craig A, Thi, Meilinh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526955/ https://www.ncbi.nlm.nih.gov/pubmed/33014653 http://dx.doi.org/10.7759/cureus.10157 |
Ejemplares similares
-
Lipid Paradox in Statin-Naïve Acute Ischemic Stroke But Not Hemorrhagic Stroke
por: Cheng, Kai-Hung, et al.
Publicado: (2018) -
Editorial: Blood-Based Biomarkers in Acute Ischemic Stroke and Hemorrhagic Stroke
por: Uphaus, Timo, et al.
Publicado: (2022) -
Iatrogenic Delayed Pneumothorax After Transbronchial Biopsy
por: Rajdev, Kartikeya, et al.
Publicado: (2020) -
Acute Effects of Particulate Air Pollution on Ischemic Stroke and Hemorrhagic Stroke Mortality
por: Zhang, Runhua, et al.
Publicado: (2018) -
A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence
por: Rajdev, Kartikeya, et al.
Publicado: (2020)